首页> 外文期刊>American Journal of Clinical Oncology: Cancer Clinical Trials >Influence of Comorbidity on the Risk of Death A Single Institution Study of 1132 Women With Early-stage Uterine Cancer
【24h】

Influence of Comorbidity on the Risk of Death A Single Institution Study of 1132 Women With Early-stage Uterine Cancer

机译:合并症对1132名患有早期子宫癌的单一机构研究的死亡风险的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose/Objective(s): The impact of competing medical comorbidity on survival endpoints in women with early stage endometrial carcinoma (EC) is not well studied. The study goal was to utilize a validated comorbidity scoring system to determine its impact on all-cause mortality as well as on recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) in patients with early-stage EC.
机译:目的/目标:竞争医疗合并症对早期子宫内膜癌(EC)的妇女存活终点的影响并未得到很好的研究。 该研究目标是利用验证的合并症评分系统来确定其对所有原因死亡率以及早期患者患者的无催化存活(RFS),疾病特异性生存(DSS)和整体存活(OS)的影响 -stage ec。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号